• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PLIN2 通过抑制 HIF1α 的降解促进 HCC 细胞增殖。

PLIN2 promotes HCC cells proliferation by inhibiting the degradation of HIF1α.

机构信息

Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Hospital of Dalian Medical University, Dalian, 116027, China; CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.

CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.

出版信息

Exp Cell Res. 2022 Sep 1;418(1):113244. doi: 10.1016/j.yexcr.2022.113244. Epub 2022 Jun 10.

DOI:10.1016/j.yexcr.2022.113244
PMID:35697078
Abstract

PLIN2 has been found to be dysregulated in several human malignancies, which influences cancer progression. However, the roles of PLIN2 in regulating hepatocellular carcinoma (HCC) progression are still unclear. Here, we revealed that PLIN2 was frequently upregulated in HCC cells and tissues, and increased PLIN2 expression was associated with poor prognosis outcomes in HCC. In HCC cells, overexpressing PLIN2 promoted cell proliferation, PLIN2-deficiency inhibited cell vitality. Mechanistically, silencing of PLIN2 expression downregulated hypoxia inducible factor 1-α (HIF1α) expression and this downregulation in turn inhibited the targeting genes of HIF1α. Furthermore, we found that PLIN2 stabilized and retarded the degradation of the HIF1α through autophagy-lysosomal pathway by inhibiting AMPK/ULK1. Collectively, we clarified the carcinogenic role of PLIN2 in HCC and suggested a prognostic biomarker for diagnosis and clinical therapy in the future.

摘要

PLIN2 在几种人类恶性肿瘤中失调,影响癌症进展。然而,PLIN2 在调节肝细胞癌 (HCC) 进展中的作用尚不清楚。在这里,我们揭示了 PLIN2 在 HCC 细胞和组织中频繁上调,并且增加的 PLIN2 表达与 HCC 的预后不良结果相关。在 HCC 细胞中,过表达 PLIN2 促进细胞增殖,PLIN2 缺陷抑制细胞活力。在机制上,沉默 PLIN2 的表达下调了缺氧诱导因子 1-α (HIF1α) 的表达,而这种下调反过来又抑制了 HIF1α 的靶向基因。此外,我们发现 PLIN2 通过抑制 AMPK/ULK1 稳定和延迟 HIF1α 通过自噬-溶酶体途径的降解。总之,我们阐明了 PLIN2 在 HCC 中的致癌作用,并为未来的诊断和临床治疗提供了一个预后生物标志物。

相似文献

1
PLIN2 promotes HCC cells proliferation by inhibiting the degradation of HIF1α.PLIN2 通过抑制 HIF1α 的降解促进 HCC 细胞增殖。
Exp Cell Res. 2022 Sep 1;418(1):113244. doi: 10.1016/j.yexcr.2022.113244. Epub 2022 Jun 10.
2
Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.Rpn10 通过 PTEN/Akt 信号通路调节缺氧诱导因子 1α促进肝癌的进展。
Cancer Lett. 2019 Apr 10;447:1-11. doi: 10.1016/j.canlet.2019.01.020. Epub 2019 Jan 20.
3
Plin2 inhibits autophagy via activating AKT/mTOR pathway in non-small cell lung cancer.Plin2 通过激活 AKT/mTOR 通路抑制非小细胞肺癌中的自噬。
Exp Cell Res. 2024 Feb 15;435(2):113955. doi: 10.1016/j.yexcr.2024.113955. Epub 2024 Jan 30.
4
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.HIF-1α 诱导的 m6A 阅读器 YTHDF1 通过促进 ATG2A 和 ATG14 的翻译,驱动肝癌的缺氧诱导自噬和恶性转化。
Signal Transduct Target Ther. 2021 Feb 23;6(1):76. doi: 10.1038/s41392-020-00453-8.
5
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.USP22 通过 HIF1α/USP22 正反馈回路促进缺氧诱导的肝癌干细胞干性,该回路在 TP53 失活时发生。
Gut. 2020 Jul;69(7):1322-1334. doi: 10.1136/gutjnl-2019-319616. Epub 2019 Nov 27.
6
Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.低表达 microRNA-199b-5p 靶向肝癌中的缺氧诱导因子-1α,预测肝癌患者的预后。
J Gastroenterol Hepatol. 2011 Nov;26(11):1630-7. doi: 10.1111/j.1440-1746.2011.06758.x.
7
WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia.WWOX 通过控制肝组织中的 HIF1α 抑制肝实质细胞增殖和肿瘤形成。
Cell Death Dis. 2018 May 1;9(5):511. doi: 10.1038/s41419-018-0510-4.
8
Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration.锌指蛋白 267 在肝癌中上调,并促进肿瘤细胞增殖和迁移。
Exp Mol Pathol. 2011 Dec;91(3):695-701. doi: 10.1016/j.yexmp.2011.07.006. Epub 2011 Aug 5.
9
Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial β-oxidation.自噬通过激活线粒体β-氧化促进肝细胞癌进展。
J Gastroenterol. 2014 May;49(5):907-16. doi: 10.1007/s00535-013-0835-9. Epub 2013 May 24.
10
Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy.抑制 HIF1A-AS1 通过减少 HIF-1α/mTOR 介导的自噬促进饥饿诱导的肝癌细胞凋亡。
World J Surg Oncol. 2020 May 30;18(1):113. doi: 10.1186/s12957-020-01884-x.

引用本文的文献

1
PLIN2 promotes colorectal cancer progression through CD36-mediated epithelial-mesenchymal transition.PLIN2通过CD36介导的上皮-间质转化促进结直肠癌进展。
Cell Death Dis. 2025 Jul 10;16(1):510. doi: 10.1038/s41419-025-07836-1.
2
Identification and validation of five ferroptosis-related molecular signatures in keloids based on multiple transcriptome data analysis.基于多转录组数据分析的瘢痕疙瘩中五个铁死亡相关分子特征的鉴定与验证
Front Mol Biosci. 2025 Jan 6;11:1490745. doi: 10.3389/fmolb.2024.1490745. eCollection 2024.
3
Integrative analysis based on ATAC-seq and RNA-seq reveals a novel oncogene PRPF3 in hepatocellular carcinoma.
基于 ATAC-seq 和 RNA-seq 的综合分析揭示了肝癌中的一个新癌基因 PRPF3。
Clin Epigenetics. 2024 Nov 5;16(1):154. doi: 10.1186/s13148-024-01769-w.
4
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State.脂滴蛋白DHRS3是黑色素瘤细胞状态的调节因子。
Pigment Cell Melanoma Res. 2025 Jan;38(1):e13208. doi: 10.1111/pcmr.13208. Epub 2024 Oct 31.
5
Clinical pathological significance and biological function of PLIN1 in hepatocellular carcinoma: bioinformatics analysis and in vitro experiments.PLIN1 在肝细胞癌中的临床病理意义和生物学功能:生物信息学分析和体外实验。
BMC Cancer. 2024 Aug 30;24(1):1073. doi: 10.1186/s12885-024-12842-1.
6
Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin.伴有 HCC 的 MASLD 患者的心脏代谢危险因素:硬币的另一面。
Front Endocrinol (Lausanne). 2024 May 23;15:1411706. doi: 10.3389/fendo.2024.1411706. eCollection 2024.
7
Challenges in Pharmacological Intervention in Perilipins (PLINs) to Modulate Lipid Droplet Dynamics in Obesity and Cancer.干预 perilipins(PLINs)以调节肥胖和癌症中脂滴动态的药理学挑战。
Cancers (Basel). 2023 Aug 7;15(15):4013. doi: 10.3390/cancers15154013.
8
MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver.miR-22 缺失促进脂肪肝中的肝细胞癌发展。
Cells. 2022 Sep 14;11(18):2860. doi: 10.3390/cells11182860.